Baseline characteristics of the study patients (N = 526).
| Values | |
|---|---|
| Age, yrs | 49.02 (13.12) |
| Males, n (%) | 272 (51.71) |
| Duration of PsA, yrs | 10.74 (10.73) |
| BMI, kg/m2 | 29.13 (6.25) |
| PASI | 4.26 (8.38) |
| Enthesitis score, median (IQR) | 2 (1-2) |
| Time of enthesitis onset to resolution, months | 8.73 (3.48) |
| Swollen joint count | 3.30 (5.54) |
| Tender joint count | 7.72 (9.83) |
| Actively inflamed joint counta | 8.88 (10.55) |
| Damaged joint count | 4.09 (8.38) |
| Axial diseaseb, n (%) (N = 476) | 141 (29.62) |
| Dactylitis, n (%) | 108 (20.53) |
| Nail lesions at baseline, n (%) | 287 (54.56) |
| Fibromyalgia at baseline, n (%) | 127 (24.14) |
| Baseline enthesitis year, n (%) | |
| 2000-2004 | 118 (22.43) |
| 2005-2009 | 137 (26.05) |
| 2010-2014 | 129 (24.52) |
| > 2015 | 142 (27.00) |
Values are expressed as mean (SD) unless indicated otherwise.
↵aActively inflamed joint count is the sum of tender and/or swollen joints.
↵bAxial disease was defined as patients fulfilling the radiographic arm of the modified New York ankylosing spondylitis criteria (≥ bilateral grade 2 sacroiliitis or unilateral grade 3 or 4). PASI: Psoriasis Area and Severity Index.